Vishnu Chemicals Limited (BOM:516072)
India · Delayed Price · Currency is INR 601.55
0.00 (0.00%)
At close: Jun 17, 2026
Vishnu Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 16,030 | 14,466 | 12,126 | 13,910 | 10,690 |
Other Revenue | 67.06 | - | - | - | - |
| 16,097 | 14,466 | 12,126 | 13,910 | 10,690 | |
Revenue Growth (YoY) | 11.28% | 19.29% | -12.83% | 30.12% | 57.51% |
Cost of Revenue | 10,905 | 9,743 | 7,931 | 9,296 | 7,177 |
Gross Profit | 5,192 | 4,723 | 4,195 | 4,614 | 3,513 |
Selling, General & Admin | 2,637 | 2,411 | 2,157 | 2,296 | 1,956 |
Other Operating Expenses | 31.33 | 27.84 | 21.6 | 11.64 | - |
Operating Expenses | 3,081 | 2,820 | 2,515 | 2,572 | 2,186 |
Operating Income | 2,111 | 1,902 | 1,680 | 2,042 | 1,327 |
Interest Expense | -383.64 | -247.48 | -275.8 | -259.64 | -227.1 |
Interest & Investment Income | - | 83.76 | 45.06 | 13.08 | 18.44 |
Currency Exchange Gain (Loss) | - | 65.2 | 69.17 | 97.43 | 34.82 |
Other Non Operating Income (Expenses) | 226.63 | -122.87 | -90.07 | -73.47 | -33.8 |
EBT Excluding Unusual Items | 1,954 | 1,681 | 1,428 | 1,819 | 1,119 |
Gain (Loss) on Sale of Investments | - | 1.57 | 4.59 | 0.2 | 2.43 |
Gain (Loss) on Sale of Assets | - | - | 0.02 | 39.28 | 0.05 |
Asset Writedown | - | - | - | -5.83 | - |
Pretax Income | 1,954 | 1,682 | 1,437 | 1,854 | 1,123 |
Income Tax Expense | 530.79 | 415.9 | 426.43 | 488.85 | 309.41 |
Net Income | 1,423 | 1,266 | 1,011 | 1,366 | 813.93 |
Net Income to Common | 1,423 | 1,266 | 1,011 | 1,366 | 813.93 |
Net Income Growth | 12.34% | 25.26% | -25.97% | 67.78% | 135.96% |
Shares Outstanding (Basic) | 67 | 66 | 64 | 60 | 60 |
Shares Outstanding (Diluted) | 67 | 66 | 64 | 60 | 60 |
Shares Change (YoY) | 2.19% | 3.55% | 6.47% | - | - |
EPS (Basic) | 21.14 | 19.23 | 15.90 | 22.86 | 13.63 |
EPS (Diluted) | 21.14 | 19.23 | 15.90 | 22.86 | 13.63 |
EPS Growth | 9.93% | 20.96% | -30.46% | 67.76% | 135.96% |
Free Cash Flow | -1,301 | 23.77 | -528.47 | 168.85 | 110.63 |
Free Cash Flow Per Share | -19.33 | 0.36 | -8.31 | 2.83 | 1.85 |
Dividend Per Share | 0.300 | 0.300 | 0.300 | 0.400 | 0.400 |
Dividend Growth | - | - | -25.00% | - | 100.00% |
Gross Margin | 32.25% | 32.65% | 34.59% | 33.17% | 32.86% |
Operating Margin | 13.11% | 13.15% | 13.86% | 14.68% | 12.41% |
Profit Margin | 8.84% | 8.76% | 8.34% | 9.82% | 7.61% |
Free Cash Flow Margin | -8.08% | 0.16% | -4.36% | 1.21% | 1.03% |
EBITDA | 2,524 | 2,274 | 2,006 | 2,300 | 1,552 |
EBITDA Margin | 15.68% | 15.72% | 16.54% | 16.54% | 14.52% |
D&A For EBITDA | 413.11 | 371.74 | 325.47 | 258.47 | 225.58 |
EBIT | 2,111 | 1,902 | 1,680 | 2,042 | 1,327 |
EBIT Margin | 13.11% | 13.15% | 13.86% | 14.68% | 12.41% |
Effective Tax Rate | 27.17% | 24.72% | 29.67% | 26.36% | 27.54% |
Revenue as Reported | 16,324 | 14,619 | 12,251 | 14,062 | 10,748 |